Dubai Telegraph - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.226203
AFN 73.071893
ALL 93.960321
AMD 423.724896
ANG 2.060342
AOA 1055.835022
ARS 1653.354187
AUD 1.639764
AWG 2.071386
AZN 1.955326
BAM 1.939252
BBD 2.318912
BDT 141.335156
BGN 1.945814
BHD 0.43396
BIF 3441.95307
BMD 1.15077
BND 1.475013
BOB 7.984862
BRL 5.858341
BSD 1.151375
BTN 108.817416
BWP 15.427352
BYN 3.187599
BYR 22555.092
BZD 2.31564
CAD 1.622315
CDF 2669.786539
CHF 0.919891
CLF 0.025899
CLP 1019.305887
CNY 7.776271
CNH 7.7963
COP 3952.89495
CRC 524.424864
CUC 1.15077
CUP 30.495405
CVE 109.726009
CZK 23.938375
DJF 204.514691
DKK 7.406517
DOP 67.435057
DZD 152.913136
EGP 57.432856
ERN 17.26155
ETB 182.253223
FJD 2.570475
FKP 0.856318
GBP 0.86513
GEL 3.043786
GGP 0.856318
GHS 13.001054
GIP 0.856318
GMD 84.005847
GNF 10100.882542
GTQ 8.776185
GYD 240.844771
HKD 9.016467
HNL 30.722333
HRK 7.534434
HTG 150.366857
HUF 345.978589
IDR 20424.556422
ILS 3.390134
IMP 0.856318
INR 108.528541
IQD 1507.5087
IRR 1582308.749934
ISK 143.07527
JEP 0.856318
JMD 182.096098
JOD 0.815918
JPY 184.425851
KES 149.047935
KGS 100.634562
KHR 4617.456644
KMF 489.077033
KPW 1035.693403
KRW 1739.808883
KWD 0.35455
KYD 0.959512
KZT 561.483746
LAK 25351.462874
LBP 103051.453562
LKR 385.721827
LRD 209.61256
LSL 18.636557
LTL 3.397924
LVL 0.696089
LYD 7.336181
MAD 10.638889
MDL 20.09155
MGA 4833.233941
MKD 61.09051
MMK 2415.980579
MNT 4116.679238
MOP 9.289529
MRU 46.122914
MUR 54.236067
MVR 17.791185
MWK 1997.737016
MXN 19.912233
MYR 4.677655
MZN 73.536625
NAD 18.64468
NGN 1564.034121
NIO 42.129805
NOK 11.063848
NPR 174.106761
NZD 1.992227
OMR 0.442469
PAB 1.151375
PEN 3.927015
PGK 5.049291
PHP 69.475448
PKR 320.257204
PLN 4.197629
PYG 7026.04384
QAR 4.189381
RON 5.186562
RSD 116.309537
RUB 83.973466
RWF 1712.34576
SAR 4.317567
SBD 9.276845
SCR 16.24326
SDG 691.036606
SEK 10.942217
SGD 1.475321
SHP 0.859166
SLE 28.481893
SLL 24131.075732
SOS 657.673717
SRD 42.960576
STD 23818.615605
STN 24.626478
SVC 10.074121
SYP 127.197022
SZL 18.638884
THB 37.439728
TJS 10.673122
TMT 4.039203
TND 3.350755
TOP 2.770778
TRY 53.456132
TTD 7.821258
TWD 36.316578
TZS 3020.774668
UAH 51.564725
UGX 4259.650626
USD 1.15077
UYU 46.483739
UZS 13814.993686
VES 685.900804
VND 30295.17102
VUV 137.232574
WST 3.152781
XAF 650.406808
XAG 0.016857
XAU 0.000269
XCD 3.110014
XCG 2.075074
XDR 0.809794
XOF 650.185256
XPF 119.331742
YER 274.60252
ZAR 18.845855
ZMK 10358.309615
ZMW 20.350342
ZWL 370.54747
  • RBGPF

    -1.7300

    61.14

    -2.83%

  • CMSC

    -0.0450

    22.32

    -0.2%

  • CMSD

    0.0300

    22.29

    +0.13%

  • BCE

    -0.5400

    23.28

    -2.32%

  • GSK

    -0.0700

    52.15

    -0.13%

  • BCC

    -0.7500

    70.81

    -1.06%

  • RIO

    -3.0700

    102.67

    -2.99%

  • NGG

    -1.6000

    80.68

    -1.98%

  • BTI

    -1.8900

    59.49

    -3.18%

  • AZN

    -0.8200

    177.89

    -0.46%

  • JRI

    -0.1900

    12.62

    -1.51%

  • RELX

    -0.7900

    32.01

    -2.47%

  • RYCEF

    -0.1600

    18.43

    -0.87%

  • VOD

    -0.3600

    14.53

    -2.48%

  • BP

    -1.0100

    40.14

    -2.52%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

Y.El-Kaaby--DT